DeepMed Research

Cincinnati Children's Hospital Medical Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1883-01-01

Employees: 10K

Market Cap: -

Website: http://www.cincinnatichildrens.org

Clinical Trials

Dipyridamole/Magnesium To Improve Sickle Cell Hydration

Phase 2

Withdrawn

Conditions: Anemia, Sickle Cell

First Posted Date: 2006-01-13

Last Posted Date: 2013-08-07

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Registration Number: NCT00276146

Locations: 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States
🇺🇸
Karmanos Cancer Institute, Detroit, Michigan, United States

Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy

Phase 1

Terminated

Conditions: Glioblastoma Multiforme (WHO Grade IV)
Anaplastic Astrocytoma (WHO Grade III)

First Posted Date: 2006-01-09

Last Posted Date: 2012-08-29

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Target Recruit Count: 1

Registration Number: NCT00272870

Locations: 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders

Recruiting

Conditions: Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease
Food Allergy

First Posted Date: 2005-12-21

Last Posted Date: 2024-08-05

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Target Recruit Count: 5000

Registration Number: NCT00267501

Locations: 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome

Phase 1

Completed

Conditions: Eosinophilic Gastroenteritis
Churg-Strauss Syndrome
Eosinophilic Esophagitis
Hypereosinophilic Syndromes

Interventions: Drug: Mepolizumab

First Posted Date: 2005-12-19

Last Posted Date: 2020-07-29

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Target Recruit Count: 24

Registration Number: NCT00266565

Locations: 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas

Not Applicable

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2005-11-15

Last Posted Date: 2014-01-06

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Registration Number: NCT00253487

Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia

Phase 1

Completed

Conditions: Fanconi Anemia

Interventions: Drug: Oxandrolone

First Posted Date: 2005-10-24

Last Posted Date: 2011-07-15

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Target Recruit Count: 10

Registration Number: NCT00243399

Locations: 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

Behavioral & Nutritional Treatment to Help CF Preschoolers Grow

Not Applicable

Completed

Conditions: Pancreatic Cystic Fibrosis
Cystic Fibrosis

Interventions: Behavioral: Education and Attention Control
Behavioral: Behavioral and Nutrition Treatment

First Posted Date: 2005-10-19

Last Posted Date: 2018-05-22

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Target Recruit Count: 78

Registration Number: NCT00241969

Locations: 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
🇺🇸
Rainbows and Babies Children's Hospital, Cleveland, Ohio, United States

and more 2 locations

Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders

Phase 3

Completed

Conditions: Bipolar Disorder

Interventions: Other: Placebo
Drug: Risperidone oral solution
Drug: Valproate Oral Solution

First Posted Date: 2005-09-22

Last Posted Date: 2020-10-20

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Target Recruit Count: 46

Registration Number: NCT00221403

Locations: 🇺🇸
Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder

Phase 3

Completed

Conditions: Bipolar Disorder

First Posted Date: 2005-09-22

Last Posted Date: 2024-02-08

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Target Recruit Count: 153

Registration Number: NCT00221429

Locations: 🇺🇸
University of Cincinnati Medical Center/Medical Sciences Building, Cincinnati, Ohio, United States

Role of Carbohydrate Modification in Weight Management Among Obese Children

Not Applicable

Completed

Conditions: Childhood Obesity

Interventions: Behavioral: Low carbohydrate, reduced glycemic load, and a control diet

First Posted Date: 2005-09-22

Last Posted Date: 2015-02-05

Lead Sponsor: Children's Hospital Medical Center, Cincinnati

Target Recruit Count: 102

Registration Number: NCT00215111

Locations: 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy